Funding is needed to Support our work
To ensure the continued funding of the ICCR we are seeking $20K per dataset to ensure we are able to continue delivering datasets for worldwide use. Please consider donating or sponsoring the development of an ICCR dataset.
1. What is the role of pathology in cancer?
Pathology reports provide the fundamental information required for the treatment of all cancers. Most significant treatment decisions are based on the pathology report which:
The magnitude of the surgical intervention and the extent and type of treatment is all based on the pathology report details. It is the pathology report that dictates management and prognosis by detailing the disease process. In addition, the pathology report is the most significant source of information for cancer registries providing information for cancer care planning and resource distribution at a national level.
- provides the definitive diagnosis
- includes information necessary for staging,
- evaluates the adequacy of the surgical excision,
- gives a determination of appropriate chemotherapy and/or radiation therapy
- and identifies important prognostic indicators.
2. How does it affect a patient’s cancer journey?
The pathology report is the foundation of a patient’s cancer journey. Having accurate and complete information in their pathology report means that patients receive the most effective and timely treatment. Equally important, having the correct information means they do not receive treatments that will not help them and may cause complications or toxicity.
3. How does it affect patient outcomes?
Aside from the personal benefits of correct treatment, standardised cancer datasets are the means of raising the standard of pathology cancer reports worldwide, particularly in those countries not able to produce cancer datasets themselves.
Standardised cancer datasets are the foundation for national and international benchmarking in cancer monitoring and management with cost implications for both the patient and public health systems.
4. How is funding used?
The ICCR datasets are developed by world leading experts using a proven, evidence-based process which incorporates a period of international review. Using the ICCR datasets or incorporating the internationally agreed elements into local or national protocols, means that pathologists around the world can contribute to improved cancer data ascertainment at a global level.
While domain expertise for the development of the datasets is provided by the altruistic contributions of volunteer specialist pathologists and clinicians across the globe, the involvement of an ICCR Project Manager streamlines and standardises the dataset development process, reduces individual pathologists’ time and effort, optimises the development timeline and ensures implementation of, and adherence to, ICCR standards.
The cost of a Project Manager to develop a new ICCR Dataset has been estimated as $20KUSD.
To learn more about how to continue this important work, please refer to our corporate profile or email email@example.com for details.